Skyrizi Subcutaneous Injection 180mg Autodoser, containing risankizumab (genetical recombination), is a biologic medication manufactured by AbbVie. It is used for conditions like moderate to severe plaque psoriasis and active psoriatic arthritis, and is provided as a 180mg 1.2mL kit with YJ code 3999450G5023.
Skyrizi Subcutaneous Injection 180mg Autodoser
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →